Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerability.

Saved in:
Bibliographic Details
Title: Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerability.
Authors: Ryan AT; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Lawrence JIA; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA. Electronic address: austin.ryan@emory.edu., Virgin-Downey B; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Kuiper DL; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Hager MW; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Tomioka T; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Kim RS; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Asakawa AH; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Meehan MC; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Truong P; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Mao S; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Saindaine MT; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Sticher ZM; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Marengo J; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Andrews MK; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Krueger RE; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Cruz AA; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Smith ML; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Jin R; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Mitchell DG; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Kolykhalov AA; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA., Yoon JJ; Center for Translational Antiviral Research (CTAR), Georgia State University Institute for Biomedical Sciences, Atlanta, GA, 30303, USA., Lieber CM; Center for Translational Antiviral Research (CTAR), Georgia State University Institute for Biomedical Sciences, Atlanta, GA, 30303, USA., Plemper RK; Center for Translational Antiviral Research (CTAR), Georgia State University Institute for Biomedical Sciences, Atlanta, GA, 30303, USA., Painter GR; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA; Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA, 30322, USA., Natchus MG; Emory Institute for Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA.
Source: European journal of medicinal chemistry [Eur J Med Chem] 2026 Apr 15; Vol. 308, pp. 118692. Date of Electronic Publication: 2026 Feb 20.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1768-3254
DOI:10.1016/j.ejmech.2026.118692